I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
SAR439859 Plus Palbociclib as First Line Therapy for Patients With ER(+) HER2(-) Advanced Breast Cancer
Secondary Objective: To compare the overall survival in both treatment arms To evaluate the objective response rate in both treatment arms To evaluate the duration of response in both treatment arms To evaluate the clinical benefit rate in both treatment arms To evaluate the pharmacokinetics of SAR439859, goserelin, and palbociclib …
palbociclib
HER2
solid tumour
advanced breast cancer
letrozole
- 0 views
- 04 Dec, 2020
- 5 locations